Man Group
ABBV icon

Man Group’s AbbVie ABBV Stock Holding History

Man Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.87M Sell
27,300
-8,200
-23% -$1.76M 0.01% 975
2026
Q1 		$7.72M Sell
35,500
-88,800
-71% -$19.7M 0.01% 931
2025
Q4 		$28.4M Buy
124,300
+47,000
+61% +$10.7M 0.05% 377
2025
Q3 		$17.9M Buy
77,300
+37,200
+93% +$7.58M 0.03% 548
2025
Q2 		$7.44M Sell
40,100
-85,000
-68% -$15.8M 0.01% 890
2025
Q1 		$26.2M Sell
125,100
-9,800
-7% -$1.91M 0.07% 339
2024
Q4 		$24M Buy
134,900
+53,600
+66% +$9.85M 0.06% 364
2024
Q3 		$16.1M Buy
81,300
+36,300
+81% +$6.77M 0.04% 529
2024
Q2 		$7.72M Buy
45,000
+9,400
+26% +$1.56M 0.02% 824
2024
Q1 		$6.48M Sell
35,600
-3,600
-9% -$620K 0.02% 882
2023
Q4 		$6.07M Buy
+39,200
New +$5.71M 0.02% 867
2023
Q3 		– Sell
-1,100
Closed -$148K – 1896
2023
Q2 		$148K Buy
+1,100
New +$161K ﹤0.01% 1851
2023
Q1 		– Hold
0
– – – 2040

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Man Group's ABBV Position: Q2 2026 in Review

Man Group reduced its AbbVie (ABBV) stake by 4% in Q2 2026, selling an estimated $15.1M and leaving 1,704,016 shares worth $429M. The position accounts for 0.68% of the portfolio, ranked #19.

Man Group first reported a position in ABBV in Q1 2018 and has held it in 31 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Man Group held 1,704,016 shares of AbbVie worth $429M as of Q2 2026.
  • Man Group sold 70,399 AbbVie shares in Q2 2026, an estimated $15.1M.
  • AbbVie made up 0.68% of Man Group's portfolio in Q2 2026, its #19 holding.
  • Man Group first reported a position in AbbVie in Q1 2018 and has held it in 31 quarters since.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.